We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $46.3M
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
-6.42%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$976M
AUM Growth
+$257M
Cap. Flow
+$279M
Cap. Flow %
28.55%
Top 10 Hldgs %
76.43%
Holding
234
New
114
Increased
26
Reduced
16
Closed
77

Top Buys

Rank Stock Value
1
DNLI icon
Denali Therapeutics
DNLI
+$370M
2
AIG icon
American International
AIG
+$8.49M
3
AMP icon
Ameriprise Financial
AMP
+$7.55M
4
TROW icon
T. Rowe Price
TROW
+$7.55M
5
V icon
Visa
V
+$6.43M

Top Sells

Rank Stock Value
1
JUNO
Juno Therapeutics, Inc.
JUNO
+$85.7M
2
FNB icon
FNB Corp
FNB
+$8.22M
3
TRV icon
Travelers Companies
TRV
+$7.78M
4
SHW icon
Sherwin-Williams
SHW
+$7.34M
5
WTW icon
Willis Towers Watson
WTW
+$7.28M

Sector Composition

Rank Sector Weight
1 Healthcare 37.59%
2 Financials 12.34%
3 Technology 4.43%
4 Industrials 4.41%
5 Consumer Discretionary 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSL icon
51
Carlisle Companies
CSL
$14.6B
$1.61M 0.17%
+14,214
New +$1.55M
FIS icon
52
Fidelity National Information Services
FIS
$23.1B
$1.6M 0.16%
17,000
+1,457
+9% +$137K
IBM icon
53
IBM
IBM
$211B
$1.57M 0.16%
+10,722
New +$1.56M
BCPC
54
Balchem Corp
BCPC
$5.38B
$1.53M 0.16%
+18,988
New +$1.58M
ALDR
55
DELISTED
Alder Biopharmaceuticals
ALDR
$1.52M 0.16%
+132,658
New +$1.48M
ATKR icon
56
Atkore
ATKR
$2.46B
$1.5M 0.15%
+69,947
New +$1.4M
AHL
57
DELISTED
ASPEN Insurance Holding Limited
AHL
$1.5M 0.15%
+36,887
New +$1.53M
TRU icon
58
TransUnion
TRU
$15.1B
$1.5M 0.15%
+27,221
New +$1.45M
NCLH icon
59
Norwegian Cruise Line
NCLH
$8.51B
$1.49M 0.15%
+28,000
New +$1.55M
RIGL icon
60
Rigel Pharmaceuticals
RIGL
$681M
$1.49M 0.15%
38,420
+5,516
+17% +$210K
PARA
61
DELISTED
Paramount Global Class B
PARA
$1.48M 0.15%
+25,000
New +$1.44M
CME icon
62
CME Group
CME
$96.3B
$1.47M 0.15%
+10,088
New +$1.44M
OTIC
63
DELISTED
Otonomy, Inc.
OTIC
$1.47M 0.15%
+264,648
New +$1.15M
WPP icon
64
WPP
WPP
$4.36B
$1.45M 0.15%
+16,000
New +$1.42M
NBIX icon
65
Neurocrine Biosciences
NBIX
$16.8B
$1.45M 0.15%
18,660
-44,369
-70% -$3.03M
PYPL icon
66
PayPal
PYPL
$48.9B
$1.45M 0.15%
19,637
-16,343
-45% -$1.18M
FAF icon
67
First American
FAF
$7.66B
$1.44M 0.15%
25,775
+9,821
+62% +$529K
ORI icon
68
Old Republic International
ORI
$10.5B
$1.44M 0.15%
+67,349
New +$1.38M
CINF icon
69
Cincinnati Financial
CINF
$27.3B
$1.43M 0.15%
+19,110
New +$1.42M
AMAT icon
70
Applied Materials
AMAT
$403B
$1.43M 0.15%
+28,000
New +$1.52M
PAYX icon
71
Paychex
PAYX
$41.6B
$1.43M 0.15%
+21,000
New +$1.38M
CAKE icon
72
Cheesecake Factory
CAKE
$5.04B
$1.41M 0.14%
+29,195
New +$1.33M
TREC
73
DELISTED
Trecora Resources
TREC
$1.4M 0.14%
+103,552
New +$1.31M
NDAQ icon
74
Nasdaq
NDAQ
$52.7B
$1.39M 0.14%
+54,210
New +$1.37M
ADSK icon
75
Autodesk
ADSK
$49.5B
$1.36M 0.14%
+13,000
New +$1.52M
1 2
3
4 5

Similar funds

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
RRC
Range Rock Capital Wellesley, Massachusetts $46.7M AUM
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
NPCM
New Paradigm Capital Management Great Falls, Virginia $46.8M AUM
FCM
Firsthand Capital Management San Jose, California $46.9M AUM 114.33% 1-Year Est. Return
EGI
EAM Global Investors Solana Beach, California $47.1M AUM 320.45% 1-Year Est. Return
IPHI
Inflection Point Holdings II New York $47.3M AUM
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Crestline Management's Q4 2017 Portfolio in Review

As of Q4 2017, Crestline Management held 234 positions worth $976M, up 36% from $719M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Crestline Management deployed $279M of net new capital in Q4 2017, opening 114 new positions and adding to 26 existing holdings. Its largest new stake was Denali Therapeutics: 20,574,298 shares worth $322M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 5.7% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Juno Therapeutics, Inc., an estimated $85.7M trimmed.

  • Crestline Management's largest Q4 2017 buy was Denali Therapeutics: 20,574,298 shares worth $322M.
  • Crestline Management added most to Ameriprise Financial in Q4 2017, an estimated $7.55M increase.
  • Crestline Management's biggest Q4 2017 reduction was Juno Therapeutics, Inc., cutting an estimated $85.7M.
  • Crestline Management fully exited FNB Corp in Q4 2017, selling an estimated $8.22M.
  • Crestline Management's ten largest holdings make up 76% of its $976M portfolio in Q4 2017.
  • Crestline Management opened 114 new positions and closed 77 in Q4 2017.
  • Crestline Management's portfolio value rose 36% quarter-over-quarter to $976M.

Based on Crestline Management's 13F filing for Q4 2017, filed 14 Feb 2018.